Radium-223

Radium 223 is under investigation in clinical trial NCT02463799 (Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC). It is grouped under the following drug class(es): Radiopharmaceuticals. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include Radium Ra-223 and 223Ra radioisotope. Its PubChem CID is 6335825.

CAS No 15623-45-7
Molecular Formula Ra
Molecular Weight 223.01850 g/mol
Synonyms radium-223

Frequently Asked Questions